Supplementary Figure 3 from Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation
crossref（2023）
Abstract
PDF file - 52KB, MEHD7945A is more potent than the combination of cetuximab and erlotinib
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined